Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Endocrine System Diseases 2Breast Neoplasms 2Amenorrhea 2Thrombosis 1Neuroma 1Neoplasms 1Movement Disorders 1Motor Activity 1Lymphedema 1Health Education 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Metformin 35Clomiphene 11Letrozole 10Inositol 7Triptorelin Pamoate 5drospirenone and ethinyl estradiol combination 4Progesterone 4Folic Acid 4Ethinyl Estradiol 4Caloric Restriction 4drospirenone 3cetrorelix 3Spironolactone 3Estradiol 3Diet, Mediterranean 3Diet 3Cyproterone acetate, ethinyl estradiol drug combination 3Contraceptives, Oral 3Acupuncture Therapy 3adrenosterone 2Vitamin D 2Ultrasonography 2Thioctic Acid 2Therapeutics 2Sitagliptin Phosphate 2Simvastatin 2Pioglitazone 2Ovidrel 2Musculoskeletal Manipulations 2Hematologic Tests 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Polycystic Ovary Syndrome × Musculoskeletal Manipulations × Clear all
NCT00744510 2012-12-04

REPOS

University of Nottingham

Phase 3 Unknown
140 enrolled

Amenorrhea, Endocrine System Diseases, Polycystic Ovary Syndrome

NCT00746148 2012-12-04

REPOS

University of Nottingham

Phase 3 Unknown
140 enrolled

Amenorrhea, Endocrine System Diseases, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡